Publishing research using ab134182? Please let us know so that we can cite the reference in this datasheet.

ab134182 has been referenced in 19 publications.

  • Xu Z  et al. Effects of FHIT gene on proliferation and apoptosis of osteosarcoma cells. Oncol Lett 17:877-882 (2019). PubMed: 30655842
  • Gao Y  et al. The Effect of HER2 Single Nucleotide Polymorphisms on Cervical Cancer Susceptibility and Survival in a Chinese Population. J Cancer 10:378-387 (2019). PubMed: 30719131
  • Guo C  et al. microRNA-10b expression and its correlation with molecular subtypes of early invasive ductal carcinoma. Exp Ther Med 15:2851-2859 (2018). PubMed: 29599829
  • Yu W  et al. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients. Pathol Res Pract 214:1017-1023 (2018). IHC-P ; Human . PubMed: 29729836
  • Kwon S  et al. A Microfluidic Immunostaining System Enables Quality Assured and Standardized Immunohistochemical Biomarker Analysis. Sci Rep 7:45968 (2017). PubMed: 28378835
  • Wang H  et al. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways. BMC Cancer 17:191 (2017). PubMed: 28292264
  • Creech MK  et al. Superresolution Imaging of Clinical Formalin Fixed Paraffin Embedded Breast Cancer with Single Molecule Localization Microscopy. Sci Rep 7:40766 (2017). PubMed: 28098202
  • Barth CW  et al. Optimizing fresh specimen staining for rapid identification of tumor biomarkers during surgery. Theranostics 7:4722-4734 (2017). PubMed: 29187899
  • Humtsoe JO  et al. ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth. Oncogene 35:1554-64 (2016). PubMed: 26073080
  • Cheng Q  et al. Stiffness of the microenvironment upregulates ERBB2 expression in 3D cultures of MCF10A within the range of mammographic density. Sci Rep 6:28987 (2016). PubMed: 27383056
  • Xu J  et al. HER2 overexpression reverses the relative resistance of EGFR-mutant H1975 cell line to gefitinib. Oncol Lett 12:5363-5369 (2016). WB ; Human . PubMed: 28105244
  • Chan KK  et al. Targeting estrogen receptor subtypes (ERa and ERß) with selective ER modulators in ovarian cancer. J Endocrinol 221:325-36 (2014). Human . PubMed: 24819599
  • Jerman S  et al. OFD1 and flotillins are integral components of a ciliary signaling protein complex organized by polycystins in renal epithelia and odontoblasts. PLoS One 9:e106330 (2014). PubMed: 25180832
  • Li LL  et al. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI. Breast Cancer Res 16:R56 (2014). PubMed: 24886710
  • Zhang YJ  et al. pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members. PLoS One 8:e59086 (2013). WB ; Human . PubMed: 23516601
  • Sollome JJ  et al. HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4). Cell Signal 26:70-82 (2013). Human . PubMed: 24036211
  • Behnsawy HM  et al. Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: correlation with intravesical recurrence following transurethral resection. Urol Oncol 29:495-501 (2011). IHC-P ; Human . PubMed: 19914103
  • Ariazi EA  et al. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci U S A 108:18879-86 (2011). WB ; Human . PubMed: 22011582
  • Kawano S  et al. Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2. J Biol Chem 284:23793-805 (2009). PubMed: 19561085

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up